one month tirzepatide results Our beautiful patient is already 26 lbs down in just her first on our personalized GLP-1 Weight Loss Program and is feeling happier, healthier, and more confident than ever. She's One Month On Tirzepatide Weight

FielerRockefeller Capital ManagementCincinnatiOhio - Cincinnati$1.5M$1.6B$2.5-30M$2-20MThomas UngerRockefeller Capital ManagementCincinnatiOhio - Cincinnati$2.5M$408M$3.5-9M$2-5MJeff MumperAmeriprise Financial ServicesCincinnatiOhio - Cincinnati$100K$431M$1-20M$500K-10MBrian BascomMorgan Stanley Wealth ManagementCincinnatiOhio - Cincinnati$500K$821M$1-10M$1-10MMichael McKayUBS Wealth ManagementCincinnatiOhio - Cincinnati$3M$364M$2-20M$1.4-15MErik ShifflettWells Fargo AdvisorsCincinnatiOhio - Cincinnati$1M$668M$2.5-10M$1-2.5MFrank Parker IIIWells Fargo AdvisorsCincinnatiOhio - Cincinnati$750K$789M$1.1M-1B$500K-1.5MRyan SmallUBS Wealth ManagementCincinnatiOhio - Cincinnati$1M$395M$3-7M$2-4MLewis AssaleyMorgan Stanley Wealth ManagementCincinnatiOhio - Cincinnati$300K$660M$1-20M$2-7MStephen RenieMerrill Wealth ManagementCincinnatiOhio - Cincinnati$250K$3.3B$2-10M$250K-10MJoel HandorfGraystone Consulting from Morgan StanleyCincinnatiOhio - Cincinnati$1M$4.2B$2-10M$1-3MMaryAnn PietromonacoMorgan Stanley Wealth ManagementCincinnatiOhio - Cincinnati$500K$672M$210K-5M$1.2-6MKelly WittichUBS Wealth ManagementCincinnatiOhio - Cincinnati$2M$4.6B$3-30M$2-20MKevin RiceMerrill Wealth ManagementCincinnatiOhio - Cincinnati$2.5M$1.3B$5-250M$2.5-200MJoe KuetheRaymond James Financial ServicesLovelandOhio - Cincinnati$500K$368M$250-750K$250K-1MM

It cannot diagnose IBS, but it may reveal patterns (like methane-producing archaea linked to constipation) that help you and your clinician tailor dietary strategies, choose targeted probiotics, or adjust the pace of medication titration

Commonly deferred medications include: Antiplatelet drugs: These affect how platelets work and are often used to prevent heart attacks or strokes

People taking certain common medications including metformin for blood sugar management and proton pump inhibitors for acid reflux also face increased deficiency risk